Stockholders' Equity (Details) - $ / shares |
9 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Equity [Abstract] | |||
| Outstanding, beginning | 1,813,053 | 1,813,053 | 0 |
| Granted | 6,500 | 0 | 1,813,053 |
| Exercised | 0 | 0 | 0 |
| Outstanding, ending | 7,832,701 | 1,813,053 | 1,813,053 |
| Exercisable, ending | 7,832,701 | 1,813,053 | 1,813,053 |
| Outstanding, beginning | $ 0.20 | $ .20 | $ 0.00 |
| Granted | 0.20 | .00 | .20 |
| Exercised | 0.00 | .00 | 0.00 |
| Expired | .00 | .00 | |
| Outstanding, ending | 0.20 | .20 | .20 |
| Exercisable, ending | $ 0.20 | $ .20 | $ .20 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|